Fisher & Paykel Healthcare Corporation Limited advises that Geraldine McBride has been appointed as an additional non-executive director of the company effective 1 August 2013.
“As part of the Board’s ongoing refreshment process and following the indication from Gary Paykel and Nigel Evans that they plan to retire from the Board following the ASM this year, Geraldine is the second of the two new director appointments we are making to ensure a smooth transition when Gary and Nigel retire” said Chairman Tony Carter.
Ms McBride served as a senior executive of SAP AG and Dell Inc. Her most recent role was President of SAP North America. Ms McBride is now co-founder of MyWave, a cloud based consumer to enterprise social commerce business.
Ms McBride received a Bachelor of Science in Zoology from Victoria University of Wellington. Her successful career spans 28 years in the technology industry gaining a wealth of global experience. Her global contributions to technology and communications were recognised with a KEA World Class New Zealand Award in 2013.
The Fisher & Paykel Healthcare board has determined that Ms McBride will be an independent director. A resolution to elect Ms McBride will be put to shareholders at the company’s Annual Shareholders Meeting.
“We believe that Geraldine will bring invaluable skills and experience to further strengthen and complement the current skills and experience of our Board” Tony Carter said.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company visit www.fphcare.com
Contact: Tony Barclay, CFO on +64 9 574 0119.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
|